Shares of Mead Johnson Nutrition CO (NYSE:MJN) have been assigned a consensus recommendation of “Hold” from the fourteen analysts that are presently covering the stock. Two research analysts have rated the stock with a sell rating and twelve have given a hold rating to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $84.36.

A number of analysts have recently weighed in on MJN shares. Zacks Investment Research upgraded Mead Johnson Nutrition CO from a “sell” rating to a “hold” rating in a research report on Wednesday, April 5th. Citigroup Inc cut Mead Johnson Nutrition CO from a “buy” rating to a “neutral” rating in a research report on Monday, March 6th. William Blair cut Mead Johnson Nutrition CO from an “outperform” rating to a “market perform” rating in a research report on Monday, February 13th. Berenberg Bank upgraded Mead Johnson Nutrition CO from a “sell” rating to a “hold” rating and set a $66.00 target price on the stock in a research report on Thursday, February 2nd. Finally, Susquehanna Bancshares Inc set a $90.00 target price on Mead Johnson Nutrition CO and gave the company a “hold” rating in a research report on Saturday, April 1st.

ILLEGAL ACTIVITY NOTICE: “Mead Johnson Nutrition CO (MJN) Given Average Recommendation of “Hold” by Brokerages” was originally published by American Banking News and is owned by of American Banking News. If you are reading this story on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The legal version of this story can be read at https://www.americanbankingnews.com/2017/05/12/mead-johnson-nutrition-co-mjn-given-average-recommendation-of-hold-by-brokerages.html.

Several large investors have recently added to or reduced their stakes in the company. BlackRock Inc. raised its stake in Mead Johnson Nutrition CO by 2,802.8% in the first quarter. BlackRock Inc. now owns 11,394,361 shares of the company’s stock valued at $1,015,011,000 after buying an additional 11,001,837 shares in the last quarter. The Manufacturers Life Insurance Company bought a new stake in Mead Johnson Nutrition CO during the third quarter valued at $158,430,000. Norges Bank bought a new stake in Mead Johnson Nutrition CO during the fourth quarter valued at $102,498,000. MARSHALL WACE ASIA Ltd bought a new stake in Mead Johnson Nutrition CO during the first quarter valued at $119,656,000. Finally, Marshall Wace North America L.P. bought a new stake in Mead Johnson Nutrition CO during the first quarter valued at $119,656,000. 95.36% of the stock is owned by institutional investors and hedge funds.

Mead Johnson Nutrition CO (NYSE:MJN) traded down 0.06% on Friday, reaching $88.95. The company’s stock had a trading volume of 1,010,436 shares. The company has a market capitalization of $16.33 billion, a price-to-earnings ratio of 27.95 and a beta of 1.38. Mead Johnson Nutrition CO has a 52 week low of $69.25 and a 52 week high of $94.40. The firm’s 50 day moving average price is $88.82 and its 200-day moving average price is $80.26.

Mead Johnson Nutrition CO (NYSE:MJN) last announced its quarterly earnings results on Thursday, April 27th. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.79 by $0.01. The business had revenue of $883.50 million for the quarter, compared to analysts’ expectations of $911.63 million. Mead Johnson Nutrition CO had a negative return on equity of 125.35% and a net margin of 14.56%. The business’s quarterly revenue was down 8.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.87 EPS. On average, equities analysts predict that Mead Johnson Nutrition CO will post $3.16 EPS for the current year.

About Mead Johnson Nutrition CO

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, Latin America and North America/Europe. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.

5 Day Chart for NYSE:MJN

Receive News & Ratings for Mead Johnson Nutrition CO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition CO and related companies with MarketBeat.com's FREE daily email newsletter.